Medical Aspects of Chemical Warfare (2008) - The Black Vault

More documents

Recommendations

Info

Vesicants25. Aitken RS. Effects of accidental exposure to mustard-gas vapor. Lancet. 1943;245:602–603.26. Ruhl CM, Park DJ, Danisa O, et al. A serious skin sulfur mustard burn from artillery shell. J Emerg Med. 1994;12(2):159–166.27. Chemical Research and Development Engineering Command. Persistency Times of Chemical Agents on CARC PaintedVehicles and Sand. Aberdeen Proving Ground, Md: CRDEC; 1990. CRDEC SMCCR-OPA.28. Blewett WK. Defense Against Mustard: A P2NBC2 Review and Analysis. Aberdeen Proving Ground, Md: Physical ProtectionDirectorate; 1992. Chemical Research and Development Engineering Command Technical Report 3270.29. Mann I, Pullinger BD. A study of mustard-gas lesions of the eyes of rabbits and men. Am J Ophthalmol. 1944;26:1253–1277.30. Marshall EK Jr, Lynch V, Smith HW. On dichlorethylsulphide (mustard gas), II: Variations in susceptibility of the skinto dichlorethylsulphide. J Pharm Exp Therap. 1919;12:291–301.31. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanisms and PharmacologicalImplications. Boca Raton, Fla: CRC Press; 1991.32. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol. 1991;127:1207–1213.33. Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int J Clin Pharm Therap Toxicol. 1989;9:419–435.34. Anslow WP, Houck CR. Systemic pharmacology and pathology of sulfur and nitrogen mustards. In: Chemical WarfareAgents, and Related Chemical Problems. Parts 3–6. Washington, DC: Office of Scientific Research and Development,National Defense Research Committee, Div 9; 1946:440–478.35. Papirmeister B, Gross CL, Meier HL, Petrali JP, Johnson JB. Molecular basis for mustard-induced vesication. FundamAppl Toxicol. 1985;5:S134–S149.36. Gross CL, Meier HL, Papirmeister B, Brinkley FB, Johnson JB. Sulfur mustard lowers nicotinamide dinucleotide concentrationsin human skin grafted to athymic nude mice. Toxicol Appl Pharmacol. 1985;81:85–90.37. Meier HL, Gross CL, Papirmeister B. 2,2’-dichlorodiethyl sulfide (sulfur mustard) decreases NAD + levels in humanleukocytes. Toxicol Lett. 1987;39:109–122.38. Mol MAE, van de Ruit AMBC, Kluivers AW. NAD + levels and glucose uptake of cultured human epidermal cellsexposed to sulfur mustard. Toxicol Appl Pharmacol. 1989;98:159–165.39. Dixon M, Needham DM. Biochemical research on chemical warfare agents. Nature. 1946;158:432–438.40. Schnyder J, Bagglionoi M. Induction of plasminogen activator secretion in macrophages by electrochemical stimulationof the hexose monophosphate shunt by methylene blue. Proc Natl Acad Sci USA. 1980;77:414–417.41. Papirmeister B, Gross CL, Petrali JP, Hixson CL. Pathology produced by sulfur mustard in human skin grafts onathymic nude mice, I: Gross and light microscopic changes. J Toxicol Cutan Ocular Toxicol. 1984;3:371–391.42. Smith WJ, Gross CL, Chan P, Meier HL. The use of human epidermal keratinocytes in culture as a model for studyingsulfur mustard toxicity. Cell Biol Toxicol. 1990;6:285–291.43. Yourick JJ, Clark CR, Mitcheltree LW. Niacinamide pretreatment reduces microvesicle formation in hairless guineapigs cutaneously exposed to sulfur mustard. Fund Appl Toxicol. 1991;17:533–542.44. Petrali JP, Oglesby SB, Meier HL. Ultrastructural correlates of the protection afforded by niacinamide against sulfurmustard–induced cytotoxicology of human lymphocytes in vitro. Ultrastructural Pathol. 1990;14:253–262.297
Medical Aspects of Chemical Warfare45. Martens ME, Smith WJ. Mechanisms of sulfur mustard induced metabolic injury. In: Proceedings of the 1993 MedicalChemical Defense Bioscience Review, Baltimore, Md, 10–13 May 1993. Aberdeen Proving Ground, Md: US Army MedicalResearch Institute of Chemical Defense; 1993: 257–363. Defense Technical Information Center A275667.46. Cowan FM, Broomfield CA, Smith WJ. Effect of sulfur mustard exposure on protease activity in human peripheralblood lymphocytes. Cell Biol Toxicol. 1991;7:239–248.47. Cowan FM, Broomfield CA, Smith WJ. Inhibition of sulfur mustard-increased protease activity by niacinamide, n-acetyl cysteine or dexamethasone. Cell Biol Toxicol. 1992;8:129–138.48. Smith WJ, Cowan FM, Broomfield CA. Increased proteolytic activity in human epithelial cells following exposure tosulfur mustard. FASEB J. 1991;5:A828.49. Gentilhomme E, Neveux Y, Hua A, Thiriot C, Faure M, Thivolet J. Action of bis(betachloroethyl)sulphide (BCES) onhuman epidermis reconstituted in culture: morphological alterations and biochemical depletion of glutathione. Toxicolin Vitro. 1992;6:139–147.50. Orrenius S, Nicotera P. On the role of calcium in chemical toxicity. Arch Toxicol Suppl. 1987;11:S11–S19.51. Ministry of Defence. A literature review upon the toxicology, mechanism of action, and treatment of sulphur andnitrogen mustard poisoning. United Kingdom: Ministry of Defence; nd. Unpublished report.52. Ray R, Legere RH, Broomfield CA, Petrali JP. Mechanism of action of alkylating agents: Membrane effects. In: Proceedingsof the 1991 Medical Defense Bioscience Review, Aberdeen Proving Ground, Md, 7–8 August 1991. Aberdeen ProvingGround, Md: US Army Medical Research Institute of Chemical Defense; 1991: 139–142. AD B158588.53. Miccadei S, Kyle ME, Gilfor D, Farber JL. Toxic consequences of the abrupt depletion of glutathione in cultured rathepatocytes. Arch Biochem Biophys. 1988;265:311–320.54. Paulet G. Metabolisme cellulaire et action cutanée du sulfure d’ethyle dichlore (yperite): Role devolu au potentield’oxydation cellulaire [in French]. CR Séances Soc Bio. 1952;146:925–928.55. Elsayed NM, Omaye ST, Klain GJ, et al. Response of mouse brain to a single subcutaneous injection of the monofunctionalsulfur mustard, butyl 2-chloroethyl sulfide (BCS). Toxicol. 1989;58:11–20.56. Karnofsky DA, Graef I, Smith HW. Studies on the mechanism of action of the nitrogen and sulfur mustards in vivo.Am J Pathol. 1948;24:275–291.57. Davison C, Rozman RS, Smith PK. Metabolism of bis-beta-chloroethyl sulfide (sulfur mustard gas). Biochem Pharmacol.1961;7:65–74.58. Zhang B, Wu Y. Toxicokinetics of sulfur mustard. Chinese J Pharm Toxicol. 1987;1:188–194.59. Buscher H. Green and Yellow Cross. Conway N, trans. Cincinnati, Ohio: Kettering Laboratory of Applied Physiology,University of Cincinnati; 1944.60. Keeler JR. Lieutenant Colonel, US Army Nurse Corps. Personal communication, 1990.61. Vedder EB. Vesicants. In: Vedder EB, ed. The Medical Aspects of Chemical Warfare. Baltimore, Md: Williams & Wilkins;1925: 125–166.62. Gilchrist HL. A Comparative Study of World War Casualties From Gas and Other Weapons. Edgewood Arsenal, Md: USChemical Warfare School; 1928: 1–51.63. Balali-Mood M, Navaeian A. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In:Proceedings of the 2nd World Congress on New Compounds in Biological and Chemical Warfare, 24–27 August 1986. Ghent,Belgium: International Association of Forensic Toxicologists; 1986: 464–473.298
Page 3 and 4:
The Coat of Arms1818Medical Departm
Page 5:
Textbooks of Military MedicinePubli
Page 8 and 9:
MEDICAL ASPECTS o fCHEMICAL WARFARE
Page 10 and 11:
ContentsContributorsForeword by The
Page 12 and 13:
ContributorsMICHAEL ADLER, PhDResea
Page 14 and 15:
DONALD M. MAXWELL, MSResearch Chemi
Page 16 and 17:
ForewordThe US military has been co
Page 18 and 19:
PrefaceA significant concern for th
Page 20:
PrologueThe original edition of Med
Page 23 and 24:
xxii
Page 25 and 26:
Medical Aspects of Chemical Warfare
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 178 and 179:
Nerve AgentsChapter 5NERVE AGENTSFR
Page 180 and 181:
Nerve AgentsAbout 10,000 to 30,000
Page 182 and 183:
Nerve Agentsphorofluoridate (DFP) w
Page 184 and 185:
Nerve AgentsFig. 5-2. This schemati
Page 186 and 187:
Nerve AgentsExhibit 5-1 continuedis
Page 188 and 189:
Nerve Agentsactivity but only 15% t
Page 190 and 191:
Nerve AgentsTABLE 5-3CHEMICAL, PHYS
Page 192 and 193:
Nerve AgentsTABLE 5-4EFFECTS OF EXP
Page 194 and 195:
Nerve Agentsaffecting the other eye
Page 196 and 197:
Nerve Agentsmay cause severe rhinor
Page 198 and 199:
Nerve Agentsof jerks and tremor.Cen
Page 200 and 201:
Nerve Agentsand they were decreased
Page 202 and 203:
Nerve Agentsnerve agent toxicity on
Page 204 and 205:
Nerve Agentspatient. Decontaminatio
Page 206 and 207:
Nerve AgentsFig. 5-5. The Mark I ki
Page 208 and 209:
Nerve Agentsadministered intramuscu
Page 210 and 211:
Nerve Agentsthat hydroxamine reacti
Page 212 and 213:
Nerve AgentsOral administration may
Page 214 and 215:
Nerve AgentsTABLE 5-7RECOMMENDED TH
Page 216 and 217:
Nerve Agentsimpairment such as whee
Page 218 and 219:
Nerve Agentssuboptimal, manner. The
Page 220 and 221:
Nerve Agentsthan those who did not.
Page 222 and 223:
Nerve Agentssible for binding nerve
Page 224 and 225:
Nerve Agentsfor comparison was not
Page 226 and 227:
Nerve AgentsTABLE 5-11EFFECTS OF PY
Page 228 and 229:
Nerve Agentstivity of smooth muscle
Page 230 and 231:
Nerve Agents38. Grob D, Lilienthal
Page 232 and 233:
Nerve Agents77. McDonough JH, Shih
Page 234 and 235:
Nerve Agents117. McLeod CG Jr, Sing
Page 236 and 237:
Nerve Agents154. Tryphonas l, Veino
Page 238 and 239:
Nerve Agents193. Funckes AJ. Treatm
Page 240 and 241:
Nerve Agents235. Suzuki T, Morita H
Page 242:
Nerve Agents274. Pellegrini JE, Bak
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270: Medical Aspects of Chemical Warfare
Page 319: Medical Aspects of Chemical Warfare
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
PROCESSMedical Aspects of Chemical
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 534 and 535:
Triage of Chemical CasualtiesChapte
Page 536 and 537:
Triage of Chemical Casualtiesreceiv
Page 538 and 539:
Triage of Chemical Casualtiesentran
Page 540 and 541:
Triage of Chemical Casualtiescatego
Page 542 and 543:
Triage of Chemical CasualtiesIn a f
Page 544 and 545:
Triage of Chemical Casualtiesnose)
Page 546 and 547:
Triage of Chemical CasualtiesWith n
Page 548 and 549:
Triage of Chemical Casualties14. Sa
Page 550 and 551:
Decontamination of Chemical Casualt
Page 552 and 553:
Page 554 and 555:
Page 556 and 557:
Page 558 and 559:
Page 560 and 561:
Page 562 and 563:
Page 564 and 565:
Page 566 and 567:
Page 568 and 569:
Page 570 and 571:
Page 572 and 573:
Page 574 and 575:
Page 576 and 577:
Page 578 and 579:
Page 580:
Page 583 and 584:
Page 585 and 586:
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646:
Page 647 and 648:
Page 649 and 650:
Page 651 and 652:
Page 653 and 654:
Page 655 and 656:
Page 657 and 658:
Page 659 and 660:
Page 661 and 662:
Page 663 and 664:
Page 665 and 666:
Page 667 and 668:
Page 669 and 670:
Page 671 and 672:
Page 673 and 674:
Page 675 and 676:
Page 677 and 678:
Page 679 and 680:
Page 681 and 682:
Page 683 and 684:
Page 685 and 686:
Page 687 and 688:
Page 689 and 690:
Page 691 and 692:
Page 693 and 694:
Page 695 and 696:
Page 697 and 698:
Page 699 and 700:
Page 701 and 702:
Page 703 and 704:
Page 705 and 706:
Page 707 and 708:
Page 709 and 710:
Page 711 and 712:
Page 713 and 714:
Page 715 and 716:
Page 717 and 718:
Page 719 and 720:
Page 721 and 722:
Page 723 and 724:
Page 725 and 726:
Page 727 and 728:
Page 729 and 730:
Page 731 and 732:
Page 733 and 734:
Page 735 and 736:
Page 737 and 738:
Page 739 and 740:
Page 741 and 742:
Page 743 and 744:
Page 745 and 746:
Page 747 and 748:
• Analyze using GC-MS with methan
Page 749 and 750:
Page 751 and 752:
Page 753 and 754:
Page 755 and 756:
Page 757 and 758:
Page 759 and 760:
Page 761 and 762:
Page 763 and 764:
Page 765 and 766:
Page 767 and 768:
Page 769 and 770:
Page 771 and 772:
Page 773 and 774:
Page 775 and 776:
Page 777 and 778:
Page 779 and 780:
Page 781 and 782:
Page 783 and 784:
Page 785 and 786:
Page 787 and 788:
Page 789 and 790:
Page 791 and 792:
Page 793 and 794:
Page 795 and 796:
Page 798 and 799:
Abbreviations and AcronymsAbBreviat
Page 800:
Abbreviations and AcronymsPADPRP: p
Page 803 and 804:
Page 805 and 806:
Page 807 and 808:
Page 809 and 810:
Page 811 and 812:
Page 813 and 814:
Page 815 and 816:
Page 817 and 818:
Page 819 and 820:
Page 821 and 822:
Page 823 and 824:
Page 825 and 826:
Page 827 and 828:
Page 829 and 830:
Page 831 and 832:
Page 833 and 834:
Page 835 and 836:
Page 837 and 838:
Page 839 and 840:
Page 841 and 842:
Page 843 and 844:
Page 845:
show all

Medical Aspects of Chemical Warfare (2008) - The Black Vault

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?